期刊文献+

重症监护病房真菌感染的检出率和耐药性趋势 被引量:14

Prevalence and Resistance Characteristics of Fungal Infection in Intensive Care Unit
暂未订购
导出
摘要 目的 探讨重症监护病房(ICU)真菌感染的种类及其耐药特点,为合理选用抗真菌药物提供病原学依据。方法 2003年7月~2004年7月入住我院ICU患者86例,分析不同部位真菌培养和药敏试验标本共354份。结果 共检出159株菌株,其中白色假丝酵母菌占72.33%。常见感染部位依次为下呼吸道(69.18%)和泌尿道(26.42%)。分离的菌株对5-氟脲嘧啶、两性霉素B和伊曲康唑的耐药性均〈10%,而对氟康唑耐药率则较高。结论 白色假丝酵母菌是ICU院内获得性真菌感染的主要病原。5-氟脲嘧啶、伊曲康唑和两性霉素B对假丝酵母菌耐药性较低,而氟康唑的耐药性较高。 Objective To investigate the kinds of fungi causing hospital infection and their drug resistance characteristics to anti-fungus drugs, in order to provide guidelines of suitable anti-fungus medication for clinical infectious diseases. Methods Results of 354 samples, which were tested for category and susceptibility to common antifungal agents, were collected and analyzed. The samples were from different positions of the 86 patients admitted to the intensive care unit between July 2003 and July 2004. Results The incidence of Candida albicans infection was the highest (72.33%). Fungal infection occurred more frequently in the respiratory tract(60.00% ) , then in the urinary tract (26.67%). The separated fungi had a lower degree of resistance to 5-fluorocytosine, amphotericin B and itraconazole ( 〈 10% ) and a higher resistance to fluconazole. Conclusion The pathogens causing fungus infection in our hospital were mainly Candida albicans. The resistance characteristics to 5-fluorocytosine, amphotericin B and itraconazole were relatively weak, but to fluconazole was strong.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第1期90-92,共3页 Journal of Shanghai Jiao tong University:Medical Science
关键词 重症监护 真菌感染 假丝酵母菌 耐药性 intensive care unit fungal infection Candida albican resistance to drugs
  • 相关文献

参考文献9

  • 1[1]Shelton BK.Opportunistic fungal infections in the critically ill[J].Crit Care Nurs Clin North Am,2000,12 (3):323-340.
  • 2尹有宽,张继明,黄玉仙,石尧忠,翁心华.医院内深部真菌感染的前瞻性调查[J].中华医院感染学杂志,2004,14(11):1308-1310. 被引量:75
  • 3陈亚红,姚婉贞,王建丽.重症监护病房肺部真菌感染的诊断与治疗[J].中华结核和呼吸杂志,2004,27(3):197-200. 被引量:79
  • 4[4]Richards MJ,Edwards JR,Culver DH,et al.Nosocomial infections in medical intensive care units in the United States.National Nosocomial Infections Surveillance system[J].Crit Care Med,1999,27(5):887-892.
  • 5赵凤芹,苏洁平,李立.老年肺癌患者呼吸道深部真菌感染临床分析[J].中华医院感染学杂志,2004,14(9):1002-1003. 被引量:21
  • 6[6]Vincent JL,Anaissie E,Bruining H,et al.Epidemiology,diagnosis and treatment of systemic Candida infection in surgical patients under intensive care[J].Intens Care Med,1998,24(3):206-216.
  • 7[7]Alberti C,Brun-Buisson C,Burchardi H,et al.Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study[J].Intens Care Med,2002,28(2):525-526.
  • 8[8]Liebowitz LD,Ashbee HR,Evans EG,et al.A two year global evaluation of susceptibility of Candida species to fluconazole by disk diffusion[J].Diagn Microbiol Infect Dis,2001,40(1-2):27-33.
  • 9刘洪涛,张军东,曹永兵,姜远英.真菌耐药性研究进展[J].中国药学杂志,2003,38(5):328-331. 被引量:39

二级参考文献36

  • 1杜斌,陈德昌,刘大为,徐英春,谢秀丽,陈民钧.综合性加强医疗病房的获得性细菌感染[J].中华医学杂志,1996,76(4):262-266. 被引量:39
  • 2[1]Fridkin S, Jarvis W. Epidemiology of nosocomial fungal infections[J]. Clin Microbiol Rev, 1996, 9(4): 499-511.
  • 3[2]Berrouane Y, Herwaldt L, Pfaller M. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital[J]. J Clin Microbiol, 1999, 37(3): 531-537.
  • 4[3]Kauffman A, Vazquez A, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients[J]. Clin Infect Dis, 2000, 30(1): 14-18.
  • 5Stevens DA. Therapy for opportunistic fungal infectious: past,present and future[ J ]. Indian J Cancer, 1995,32 (1) : 1.
  • 6Powderly WG,Keath M, Anderson S, et al. Amphotericin B-resistant Cyptococcus neoformans in a patient with AIDS[J]. Infect Dis Clin Pract , 1990,1 : 314.
  • 7Louie A,Kaw P,Banerjee P, et al. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endoearditis and pyelonephritis [ J ]. Anti Agents Chem ,2001,45(2) :485.
  • 8Yamaguchi H. Molecular and biochemical mechanisms of drug resistance in fungi [ J ]. Nippon Ishinkin Gakkai Zasshi, 1999,40(4) : 199.
  • 9Kohli A,Smriti,Mukhopadhyay K, et al. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry[J]. Anti Agents Chem,2002,46(4): 1046.
  • 10Loftier J, Einsele H, Hebart H, et al. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains[J]. FEMS Microbiol Lett ,2000,185(1) :59.

共引文献207

同被引文献84

引证文献14

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部